Skip to main content
. 2021 Mar 10;12(9):2787–2796. doi: 10.7150/jca.55477

Figure 2.

Figure 2

Premenopausal lignans intake or enterolactone in vivo and risk of all‑cause and breast cancer-specific mortality. (A) risk of all‑cause mortality, (B) risk of breast cancer-specific mortality.